Skip to main content
Caplight Logo









Cilcare

Cilcare

Private
MontpellierHealthcare & Life Scienceshttps://www.cilcare.com/

Last Round

Series A

Dec 4, 2024

Total Funding Raised

$46.84M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cilcare is a biotechnology company that specializes in auditory sciences, providing research and development services and developing proprietary drug candidates for the treatment of hearing disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

contract research organizationCROauditory researchdrug developmenthearing lossotologypreclinical researchclinical trialsauditory biomarkerstinnitus researchototoxicityauditory analyticsbiotech servicesdigital auditory signaturesneuro-otology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cilcare Comparables

Compare Cilcare with similar companies based on industry and business-model similarity.

Cilcare comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Turner Scientific
77%
PharmaLegacy
65%
Neuroservices-Alliance
65%

Cilcare Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 4, 2024
GrantJun 27, 2024
Pre SeedDec 1, 2014
SeedJul 1, 2014

Key People

Founding team and executive leadership

Celia Belline

Chief Executive Officer

Executive Team

Cilcare Investors

Notable investors and investment history

Cilcare investors
InvestorRounds
SofilaroSeed, Series A
Shionogi & Co.Series A
Créalia OccitaniePre Seed, Seed
SPRIM Global InvestmentsSeries A
Occitanie AngelsPre Seed, Seed
BpifranceGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 40% MoM.

  • Jun 20, 2026

    Monthly visitors grew 47% MoM, reaching 3.9K.

Cilcare Filings

Explore SEC and related filing metadata, where available.

Cilcare filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cilcare's valuation, stock price, and market status.

Is Cilcare a public or private company?

Cilcare is a private company.

What is the current stock price of Cilcare?

Cilcare is a private company with no public stock price. No recent secondary market data is available.

How much is Cilcare worth (valuation)?

Valuation information for Cilcare is not publicly available.

Can I buy Cilcare stock?

Cilcare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cilcare's last funding round?

Cilcare's most recent funding round was Series A on December 4, 2024.

Who are the main investors in Cilcare?

Key investors in Cilcare include Sofilaro, Shionogi & Co., Créalia Occitanie, SPRIM Global Investments, Occitanie Angels.

Will Cilcare IPO soon?

No public IPO plans have been announced for Cilcare.

How can I track Cilcare secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cilcare's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontpellier
Employee Range61
Year Founded2014
Last FundingDec 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?